{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:34:20Z","timestamp":1790890460204,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100015098","name":"Seoul Metropolitan Government Seoul National University Boramae Medical Center","doi-asserted-by":"publisher","award":["2017-0029"],"award-info":[{"award-number":["2017-0029"]}],"id":[{"id":"10.13039\/501100015098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.jiac.2021.08.003","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T19:47:50Z","timestamp":1629143270000},"page":"1694-1699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Comparison of QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube tests for patients with active and latent tuberculosis: A prospective cohort study"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5060-7255","authenticated-orcid":false,"given":"Jung-Kyu","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Young","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Joon","family":"Yim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deog Kyeom","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2021.08.003_bib1","series-title":"Global tuberculosis report 2019","author":"World Health Organization","year":"2019"},{"key":"10.1016\/j.jiac.2021.08.003_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a Re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.jiac.2021.08.003_bib3","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1056\/NEJMsa031667","article-title":"Priorities for the treatment of latent tuberculosis infection in the United States","volume":"350","author":"Horsburgh","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2021.08.003_bib4","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1164\/rccm.201406-1159OC","article-title":"Risk of tuberculosis after recent exposure. A 10-year follow-up study of contacts in Amsterdam","volume":"190","author":"Sloot","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2021.08.003_bib5","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/j.rmed.2006.02.032","article-title":"Diagnosis of latent tuberculosis infection: the potential role of new technologies","volume":"100","author":"Kunst","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.jiac.2021.08.003_bib6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1183\/09031936.00114810","article-title":"Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis","volume":"37","author":"Sester","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2021.08.003_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma interferon release assays for detection of Mycobacterium tuberculosis infection","volume":"27","author":"Pai","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jiac.2021.08.003_bib8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.immunol.19.1.93","article-title":"Immunology of tuberculosis","volume":"19","author":"Flynn","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jiac.2021.08.003_bib9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1615\/CritRevImmunol.v26.i4.30","article-title":"Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity","volume":"26","author":"Woodworth","year":"2006","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.jiac.2021.08.003_bib10","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.4049\/jimmunol.1101122","article-title":"Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load","volume":"187","author":"Day","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jiac.2021.08.003_bib11","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1183\/13993003.00510-2016","article-title":"First evaluation of QuantiFERON-TB Gold Plus performance in contact screening","volume":"48","author":"Barcellini","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2021.08.003_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01854-19","article-title":"Comparative results of QuantiFERON-TB gold in-tube and QuantiFERON-TB gold plus assays for detection of tuberculosis infection in clinical samples","volume":"58","author":"Won","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jiac.2021.08.003_bib13","doi-asserted-by":"crossref","first-page":"690","DOI":"10.5588\/ijtld.16.0764","article-title":"The sensitivity of the QuantiFERON((R))-TB Gold Plus assay in Zambian adults with active tuberculosis","volume":"21","author":"Telisinghe","year":"2017","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.jiac.2021.08.003_bib14","doi-asserted-by":"crossref","first-page":"617","DOI":"10.5588\/ijtld.17.0721","article-title":"Multicenter study of QuantiFERON((R))-TB Gold Plus in patients with active tuberculosis","volume":"22","author":"Horne","year":"2018","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.jiac.2021.08.003_bib15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.tube.2017.06.002","article-title":"Analytical evaluation of QuantiFERON- plus and QuantiFERON- gold in-tube assays in subjects with or without tuberculosis","volume":"106","author":"Petruccioli","year":"2017","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jiac.2021.08.003_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00614-18","article-title":"Comparison of the QuantiFERON-TB gold plus and QuantiFERON-TB gold in-tube interferon gamma release assays in patients at risk for tuberculosis and in Health care workers","volume":"56","author":"Theel","year":"2018","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jiac.2021.08.003_bib17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.advms.2019.09.001","article-title":"Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube interferon-gamma release assays: a systematic review and meta-analysis","volume":"64","author":"Pourakbari","year":"2019","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.jiac.2021.08.003_bib18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/thx.2010.143180","article-title":"Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review","volume":"67","author":"Zwerling","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.jiac.2021.08.003_bib19","doi-asserted-by":"crossref","first-page":"e2489","DOI":"10.1371\/journal.pone.0002489","article-title":"The effects of HIV on the sensitivity of a whole blood IFN-gamma release assay in Zambian adults with active tuberculosis","volume":"3","author":"Raby","year":"2008","journal-title":"PloS One"},{"key":"10.1016\/j.jiac.2021.08.003_bib20","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/thoraxjnl-2015-207811","article-title":"Effect of immunosuppressive therapy on interferon gamma release assay for latent tuberculosis screening in patients with autoimmune diseases: a systematic review and meta-analysis","volume":"71","author":"Wong","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.jiac.2021.08.003_bib21","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jinf.2016.09.008","article-title":"First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB plus","volume":"73","author":"Petruccioli","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.jiac.2021.08.003_bib22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jinf.2019.01.007","article-title":"CD8 response measured by QuantiFERON-TB Gold Plus and tuberculosis disease status","volume":"78","author":"Lee","year":"2019","journal-title":"J Infect"},{"key":"10.1016\/j.jiac.2021.08.003_bib23","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1164\/rccm.200306-837OC","article-title":"Mycobacterium tuberculosis-specific CD8+ T cells preferentially recognize heavily infected cells","volume":"168","author":"Lewinsohn","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2021.08.003_bib24","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/eji.201243262","article-title":"Mycobacterium tuberculosis-specific CD8+ T cells are functionally and phenotypically different between latent infection and active disease","volume":"43","author":"Rozot","year":"2013","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jiac.2021.08.003_bib25","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jinf.2020.02.009","article-title":"Effect of HIV-infection on QuantiFERON-plus accuracy in patients with active tuberculosis and latent infection","volume":"80","author":"Petruccioli","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.jiac.2021.08.003_bib26","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1183\/09031936.00089510","article-title":"Time interval to conversion of interferon-gamma release assay after exposure to tuberculosis","volume":"37","author":"Lee","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2021.08.003_bib27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.diagmicrobio.2012.11.023","article-title":"Antigen-specific CD4- and CD8-positive signatures in different phases of Mycobacterium tuberculosis infection","volume":"75","author":"Nikolova","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2021.08.003_bib28","series-title":"Global tuberculosis report 2018","author":"World Health Organization","year":"2018"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21002154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21002154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:02:14Z","timestamp":1761159734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X21002154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1341321X21002154"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2021.08.003","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube tests for patients with active and latent tuberculosis: A prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2021.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}